Истраживачи



Филтрирано по:
Година:  [2020 TO 2025]
Тип:  Научни чланак
Година:  2023

ГодинаНасловАутор(и)Тип резултатаМп-кат.
2023Has the time come to step up to "triple therapy" for the treatment of diabetic kidney disease? (✓)Patoulias, Dimitrios; Popović, Đorđe S  ; Fragakis, Nikolaos; Rizzo, ManfrediНаучни чланак
21M21 - Рад у врхунском међ. часопису
2023A Mediterranean Eating Pattern Combining Energy and Time-Restricted Eating Improves Vaspin and Omentin Concentrations Compared to Intermittent Fasting in Overweight Individuals (✓)Karras, Spyridon N; Koufakis, Theocharis; Popovic, Djordje S  ; Adamidou, Lilian; Karalazou, Paraskevi; Thisiadou, Katerina; Zebekakis, Pantelis; Makedou, Kali; Kotsa, KalliopiНаучни чланак
21M21 - Рад у врхунском међ. часопису
2023Efficacy and safety of once-weekly versus once-daily basal insulin analogues in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis (✓)Karakasis, Paschalis; Patoulias, Dimitrios; Pamporis, Konstantinos; Popovic, Djordje S  ; Stachteas, Panagiotis; Bougioukas, Konstantinos I; Fragakis, Nikolaos; Rizzo, ManfrediНаучни чланак
21M21 - Рад у врхунском међ. часопису
2023The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials (✓)Bica, Ioana-Cristina; Stoica, Roxana Adriana; Salmen, Teodor; Janez, Andrej; Volcansek, Spela; Popovic, Đorđe S  ; Muzurovic, Emir; Rizzo, Manfredi; Stoian, Anca PanteaНаучни чланак
22M22 - Рад у истакнутом међ. часопису
2023Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs - The CAPISCO International Expert Panel (✓)Popović, Đorđe S  ; Papanas, Nikolaos; Koufakis, Theocharis; Kotsa, Kalliopi; Mahmeed, Wael Al; Al-Rasadi, Khalid; (broj koautora 28)Научни чланак
23M23 - Рад у међ. часопису
2023Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials (✓)Patoulias, Dimitrios; Popovic, Djordje S  ; Pantea-Stoian, Anca; Janez, Andrej; Sahebkar, Amirhossein; Rizzo, ManfrediНаучни чланак
23M23 - Рад у међ. часопису
2023GLP-1 Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: from Molecular Mechanisms to Clinical Considerations and Practical Recommendations for Safe and Effective Use (✓)Arvanitakis, Konstantinos; Koufakis, Theocharis; Popović, Đorđe S  ; Maltese, Giuseppe; Mustafa, Omar; Doumas, Michael; Giouleme, Olga; Kotsa, Kalliopi; Germanidis, GeorgiosНаучни чланак
21aM21a - Рад у међ. часопису изузетних вредности